FDA recall D-0978-2018
Mylan Pharmaceuticals Inc. · Class III · drug
Product
Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01
Reason for recall
Subpotent Drug
Distribution
Nationwide within the United States
Key facts
- Status
- Terminated
- Initiation date
- 2018-07-09
- Report date
- 2018-07-18
- Termination date
- 2020-01-16
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Morgantown, WV, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0978-2018